Differential effects of immunotherapy with antibodies targeting α-synuclein oligomers and fibrils in a transgenic model of synucleinopathy
- DOI
- 10.1016/j.nbd.2017.05.002
- Published
- 08
- Container
- Neurobiology of Disease
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
serious concern Score 18/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- serious concernRetraction Watch retraction: 1 retraction notice matched this DOI.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.nbd.2017.05.002,
title = {Differential effects of immunotherapy with antibodies targeting α-synuclein oligomers and fibrils in a transgenic model of synucleinopathy},
author = {Omar El-Agnaf and Cassia Overk and Edward Rockenstein and Michael Mante and Jazmin Florio and Anthony Adame and Nishant Vaikath and Nour Majbour and Seung-Jae Lee and Changyoun Kim and Eliezer Masliah and Robert A. Rissman},
year = {2017},
journal = {Neurobiology of Disease},
doi = {10.1016/j.nbd.2017.05.002},
url = {https://doi.org/10.1016/j.nbd.2017.05.002}
}RIS
TY - JOUR TI - Differential effects of immunotherapy with antibodies targeting α-synuclein oligomers and fibrils in a transgenic model of synucleinopathy AU - Omar El-Agnaf AU - Cassia Overk AU - Edward Rockenstein AU - Michael Mante AU - Jazmin Florio AU - Anthony Adame AU - Nishant Vaikath AU - Nour Majbour AU - Seung-Jae Lee AU - Changyoun Kim AU - Eliezer Masliah AU - Robert A. Rissman PY - 2017 JO - Neurobiology of Disease DO - 10.1016/j.nbd.2017.05.002 UR - https://doi.org/10.1016/j.nbd.2017.05.002 ER -
APA
El-Agnaf, O., Overk, C., Rockenstein, E., Mante, M., Florio, J., Adame, A., Vaikath, N., Majbour, N., Lee, S., Kim, C., Masliah, E., & Rissman, R. A. (2017). Differential effects of immunotherapy with antibodies targeting α-synuclein oligomers and fibrils in a transgenic model of synucleinopathy. Neurobiology of Disease. https://doi.org/10.1016/j.nbd.2017.05.002
Source records
- doaj · retrieved 2026-09-24T19:25:28.730Z